PCM
PROF

PenderFund Capital Management’s Profound Medical PROF Stock Holding History

PenderFund Capital Management’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.5K Hold
9,400
– – 0.01% 185
2026
Q1 		$60.1K Hold
9,400
– – 0.01% 185
2025
Q4 		$73.8K Hold
9,400
– – 0.01% 172
2025
Q3 		$45.9K Hold
9,400
– – 0.01% 168
2025
Q2 		$55.9K Hold
9,400
– – 0.01% 122
2025
Q1 		$343K Hold
9,400
– – 0.09% 71
2024
Q4 		$93.9K Hold
9,400
– – 0.02% 99
2024
Q3 		$101K Buy
9,400
+2,100
+29% +$19K 0.02% 114
2024
Q2 		$85.6K Buy
+7,300
New +$58.8K 0.02% 105

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

PenderFund Capital Management's PROF Position: Q2 2026 in Review

PenderFund Capital Management held its Profound Medical (PROF) position steady in Q2 2026 at 9,400 shares worth $62.5K. The position accounts for 0.01% of the portfolio, ranked #185.

PenderFund Capital Management first reported a position in PROF in Q2 2024 and has held it in 9 quarters since. The position peaked at $343K in Q1 2025. 56 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • PenderFund Capital Management held 9,400 shares of Profound Medical worth $62.5K as of Q2 2026.
  • PenderFund Capital Management left its Profound Medical share count unchanged in Q2 2026.
  • Profound Medical made up 0.01% of PenderFund Capital Management's portfolio in Q2 2026, its #185 holding.
  • PenderFund Capital Management first reported a position in Profound Medical in Q2 2024 and has held it in 9 quarters since.
  • PenderFund Capital Management's Profound Medical position peaked at $343K in Q1 2025.
  • 56 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on PenderFund Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.